APOLLOHOSPNSEApollo Hospitals Enterprise Limited· MiscellaneousMediumNeutral
Announced Thu, 21 May · 22:25 IST

Apollo Hospitals Enterprise Limited has informed the Exchange about Scheme of Arrangement - NCLT Convened meeting of equity shareholders

Nclt Scheme FiledStrategic Transactions View source PDF

APOLLOHOSP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.0%1-day move
₹8330.00
prior close
₹8308.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2+0.1+0.3+0.1+1.0-0.8-0.6-1.3-3.0-0.4+1.9+1.7+7.3
Up moveDown movePending
AI summary

Apollo Hospitals has called an equity shareholder meeting on June 24, 2026 to approve a composite scheme involving demerger and amalgamations. The scheme will demerge the 'Identified Business Undertaking' from Apollo Hospitals into Apollo Healthtech Limited (Resultant Company), while amalgamating Apollo Healthco Limited and Keimed Private Limited into the Resultant Company. Apollo Healthtech will be renamed 'Apollo Healthco Limited' and listed on BSE/NSE. Shareholders of Apollo Hospitals will receive equity shares in the Resultant Company based on the Demerger Share Entitlement Ratio as recommended by KPMG and BDO valuation advisors. The meeting will be held via video conferencing with e-voting from June 20-23, 2026. The scheme requires NCLT approval and SEBI observation letters have been obtained.

Likely market impact

If approved, Apollo Hospitals shareholders will receive shares in a newly listed entity focused on healthtech, while Apollo Hospitals retains its hospital business. This creates a separately listed healthtech company and may unlock value for shareholders.